OrganOx Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 28
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $8.75M
Latest Deal Amount
  • Investors
  • 12

OrganOx General Information

Description

Developer of organ preservation and transplantation devices designed to minimize liver decay. The company's devices are based on warm preservation that seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells and provide nutrition, enabling healthcare providers to prevent the decay of the organ by producing bile, metabolizing glucose and maintaining a physiological pH.

Contact Information

Website
www.organox.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Oxford Science Park
  • Sherrington Building, Magdalen Centre, Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865 000000

OrganOx Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OrganOx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 08-Nov-2021 $8.75M 0000 Completed Generating Revenue
9. Later Stage VC 15-Oct-2021 000.00 000.00 000.00 Completed Generating Revenue
8. Later Stage VC 08-Jan-2020 00.000 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 31-Jan-2019 000.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC 19-Oct-2018 00.000 0000 Completed Generating Revenue
5. Later Stage VC (Series F) 10-Jun-2014 00.000 000.00 000.00 Completed Generating Revenue
4. Grant 10-Jun-2013 00.000 Completed Startup
3. Later Stage VC (Series C) 09-May-2012 00.000 00.000 000.00 Completed Startup
2. Early Stage VC (Series B) 07-Feb-2011 $4.38M $6.69M 000.00 Completed Startup
1. Early Stage VC (Series A) 15-Dec-2008 $2.31M $2.31M 00.00 Completed Startup
To view OrganOx’s complete valuation and funding history, request access »

OrganOx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.00
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series F 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series D 0,000 00.000000 000.00 000.00 00 000.00 0.00
Series C 57,560 $0.013639 $23.01 $23.01 1x $23.01 4.6%
Series B 179,273 $0.013639 $20.92 $20.92 1x $20.92 14.32%
To view OrganOx’s complete cap table history, request access »

OrganOx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of organ preservation and transplantation devices designed to minimize liver decay. The company's devices are
Other Devices and Supplies
Oxford, United Kingdom
28 As of 2021
0000
0000000000 0 0000

00000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dol
00000 0000000 000 00000000
Andover, MA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

000000 0

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
00000 0000000 000 00000000
Wayne, PA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OrganOx Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TransMedics Formerly VC-backed Andover, MA 000 00000 00000000 00000
000000 00000000 Formerly VC-backed Wayne, PA 00 00000 000000&0 00000
000000 0000000 000 Formerly PE-Backed Rochester, MN 00 000000000000
0000000 Venture Capital-Backed Houston, TX 00 000.00 0000000000 000.00
0000000 Corporation Danvers, MA 0000 000.00 00000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

OrganOx Patents

  • 30

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

OrganOx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10362780-B2 Oxygen supply for organ perfusion systems Active 10-Nov-2011 0000000000 0
CA-2855341-C Oxygen supply for organ perfusion systems Active 10-Nov-2011 0000000000
GB-2509875-A Oxygen supply for organ perfusion systems Granted 10-Nov-2011 0000000000
GB-2509875-B Oxygen supply for organ perfusion systems Active 10-Nov-2011 0000000000
ES-2711104-T3 Oxygen supply for organ perfusion systems Active 10-Nov-2011 A01N1/0247
To view OrganOx’s complete patent history, request access »

OrganOx Executive Team (11)

Name Title Board Seat Contact Info
Craig Marshall Chief Executive Officer & Board Member
Graham Yeatman Chief Financial Officer & Board Member
Andy Self Global Commercial Director & Director of Business Development
James Broomham Director of Operations
Andrew Cook Ph.D Software Developer
You’re viewing 5 of 11 executive team members. Get the full list »

OrganOx Board Members (12)

Name Representing Role Since
Constantin Coussios Ph.D Self Co-Founder, Board Member & Chief Technical Officer 000 0000
Craig Marshall OrganOx Chief Executive Officer & Board Member 000 0000
George Robinson Oxford Investment Consultants Board Member 000 0000
Graham Yeatman OrganOx Chief Financial Officer & Board Member 000 0000
Juliet Thompson OrganOx Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

OrganOx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrganOx Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Perivoli Innovations Trust Venture Capital Minority 000 0000 000000 0
BGF Growth/Expansion Minority 000 0000 000000 0
GT Healthcare Capital Partners Venture Capital Minority 000 0000 000000 0
Boost&Co Lender/Debt Provider Minority 000 0000 000000 0
Oxford Investment Consultants Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial